240 results
Page 5 of 12
8-K
EX-10.2
tqymqrl8aondig5
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.5
ndekvr58b14xbj0 lm
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.1
27w9 xp5095vd
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.4
lex067f82pj19
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-10.3
4rkmo0k3
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-10.2
a5y3d6pfp8dxg yrqtq
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-10.5
tkkg39s5w
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-10.1
qh7iy
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K/A
EX-10.3
3783h9cqzh
6 Mar 14
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-10.2
5jasla8uoqsgi5
6 Mar 14
Entry into a Material Definitive Agreement
12:00am